Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MGI Pharma MOGN New patents, anti cancer -- Ignore unavailable to you. Want to Upgrade?

To: seminole who wrote (655)	2/11/1998 8:15:00 PM
From: David Cathcart	Read Replies (1) \| Respond to of 1826

Richard, <<Was it something like; we have all the rights to one of the most exciting anti-tumor cancer drugs around?>> Blitzer's exact quote was: "We own all the rights to one of the most exciting anti-cancer drugs in human clinical development today." Not bad, but I like "ITS DA BOMB" better. With phase II just around the corner, we will soon see just how exciting this drug is. It is interesting that MGI-114 remains in the position to be one of the most important cancer drugs EVER developed and the market has yet to attribute ANY value to it. Phase II and a European partner could make a dramatic difference though. Yes, let's go shrink some tumors. David